InvestorsHub Logo
Followers 1
Posts 306
Boards Moderated 0
Alias Born 03/27/2011

Re: None

Wednesday, 10/09/2013 9:19:56 AM

Wednesday, October 09, 2013 9:19:56 AM

Post# of 3898
A great read for everyone:
http://www.earningsimpact.com/Transcript/83981/RNN/Rexahn-Pharmaceuticals%2c-Inc----15th-Annual-Rodman-and-Renshaw-Global-Investment-Conference#sthash.csD8Vjot.QsZmK2jF.dpbs


Even though Teva adjust terminate collaboration two weeks ago we have already got an interest expressed by a number of major Pharmaceutical companies based on publications and data that's out there with this compound Just to really talk about the relationship with Teva and the termination of the relationship with the Teva as I said, the agreement was signed back in 2009. Teva had invested over $9 million to start the program up and to get it through the first Phase I trial in Europe and through filing IND here in the United States. Once we filed the IND here in United States, Teva had a 45 day option period of which they had to exercise their option on the compound which they did not.